Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Peer support and warmth kit boost kangaroo care for tiny babies

NCT ID NCT06937580

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a program to help mothers of low birth weight babies in Ghana practice kangaroo care—skin-to-skin contact, breastfeeding, and follow-up—which is proven to save lives. 328 mothers received either standard care or extra support from trained peers and a box with warm items like a hat and a temperature monitor. The goal was to see if this support increased breastfeeding and skin-to-skin time at home, helping more babies survive.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

328 people

The number who actually took part.

Started

Jul 2025

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

15 to 49 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

The study will consider mother-infant dyads eligible for participation if they meet all of the following criteria: * Mothers aged between 15 and 49 years. * Mothers intending to initiate facility-based Kangaroo Care, irrespective of gestational age, delivery mode, or singleton or multiple birth status. * Mothers capable of providing consent or those unwilling to provide consent. * Mothers without medical complications hindering Kangaroo Care. * Mothers residing within a 10-kilometer radius of the study site. * Infants capable of spontaneous breathing within 1 hour of birth. * Infants without major congenital malformations.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Kangaroo mother care are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Korle-Bu Teaching Hospital

    Accra, Greater Accra Region, Ghana

  • Sunyani Regional Teaching Hospital

    Sunyani, Ghana

More trials for these conditions

Other studies related to the condition(s) this trial covers.